Immune-regulatory networks and disease initiation

A07

Role of IL-6 in shaping local immune milieus in the CNS

Univ.-Prof. Dr. rer. nat. Ari Waisman
Institut für Molekulare Medizin, Forschungszentrum Immuntherapie
Mainz

Univ.-Prof. Dr.med. Thomas Korn
Neurologische Universitätsklinik
TU München

 

A09

Analysis and therapeutic modifications of innate immune regulatory networks in controlling T-cell activation in MS

Univ.-Prof. Prof. h.c. Dr. med. Heinz Wiendl
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster

Dr. rer. nat. Catharina Groß
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster

 

A11

MOG Antibody-Induced CNS Demyelination: from Specificity to Function

Prof. Dr. med. Edgard Meinl
Institut für klinische Neuroimmunologie
LMU München

Univ.-Prof.Dr. med. Jan Lünemann
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster

 

A12

Provenance mapping of immune cells in the CSF

Univ.-Prof. Dr. med. Thomas Korn
Klinik für Neurologie
TU München

Priv.-Doz. Dr. med. Klaus Lehmann-Horn
Klinik für Neurologie
TU München

 

B04

Unraveling the role of myeloid cells and metabolism in clinical progression of MS

Prof. Dr. med. Stefan Bittner
Klink für Neurologie, Forschungszentrum Immuntherapie
Mainz

Univ.-Prof. Dr. rer. nat. Tobias Bopp
Institut für Immunologie, Forschungszentrum Immuntherapie
Mainz

 

B08

B cells and B cell directed therapies in CNS inflammation

Prof. Dr. med. Edgar Meinl
Institut für Klinische Neuroimmunologie
LMU München

Dr. rer nat. Anneli Peters (née Jäger)
Institut für Klinische Neuroimmunologie
LMU München

News

Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more
Wed, 20/01/2021
A new study on neurological manifestations of severe COVID-19 reveals nervous system immune deficiency
Patients suffering from COVID-19 can develop concomitant and long-term symptoms in their nervous system. The most common symptom in this context is the loss of the sense of smell and taste, while more severe symptoms such as stroke, cerebral seizures, or meningitis are possible. A team of scientists from the medical faculties at the Universities […]...more
Fri, 15/01/2021
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity
It has long been acknowledged that multiple sclerosis disease risk is associated with reduced sun-exposure, and subsequent low vitamin D levels. The study by Ostkamp et al. now assessed the relationship between measures of sun exposure and MS severity. For this, the researchers analyzed data of around 2,000 patients from the German NationMS- and the […]...more